Tian'an Technology (TANAF) Non-Current Debt (2022 - 2023)
Tian'an Technology (TANAF) posted Non-Current Debt of $100.0 million for Q2 2023, little changed on a QoQ basis from $100.0 million in Q4 2022.
Tian'an Technology (TANAF) has 2 years of Non-Current Debt data on file, last reported at $100.0 million in Q2 2023.
- In Q2 2023, Non-Current Debt changed N/A year-over-year to $100.0 million; the TTM figure through Jun 2023 stood at $100.0 million (changed N/A YoY), while the FY2022 annual figure was $100.0 million, changed N/A from the prior year.
- Non-Current Debt steadied at $100.0 million in Q2 2023, from $100.0 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $100.0 million in Q4 2022 and bottomed at $100.0 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 27.88 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.81 Bn |
| 10 | Tian'an Technology | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 100.00 Mn |
| Jun 30, 2023 | 100.00 Mn |
| Dec 31, 2022 | 100.00 Mn |
| Dec 31, 2022 | 100.00 Mn |